The active substance is the same (semaglutide), but the RUO pen and the pharmaceutical pen come from two separate regulatory frameworks with different documentation and intended use
Instead, the forward-looking statements contained in this press release are based on our current expectations, assumptions and beliefs concerning future developments and their potential effects on us
Marketed as Mounjaro for type 2 diabetes and Zepbound for chronic weight management, this once-weekly injectable medication targets two distinct hormone receptors simultaneously
Health technology assessment in Japan: a work in progress
Transparency about peptide use is essential withholding this information can lead to misdiagnosis or inappropriate treatment
How the 28-Day Timeline Fits Your Treatment Schedule Most patients using compounded semaglutide for weight loss take weekly injections on the same day each week, meaning a single vial covers approximately four weeks of treatment